Low-intensity shockwave therapy improves erectile function in trials, but guidelines continue to classify it as ...
4don MSN
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
A 2026 observational study suggests GLP-1 receptor agonists may be associated with a modest increase in erectile dysfunction ...
Between a rock-hard body and a soft place. Lifting weights has been shown to strengthen muscles, boost brain health and lower ...
Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...
Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)MOGAD is a rare autoimmune disease of the central nervous ...
Built by active duty first responders, RespondWell gives firefighters, police, EMS, and dispatchers nationwide fast access to ...
Beyond changes to your appearance, acromegaly causes “invisible” symptoms like joint pain and fatigue. Learn how to manage ...
Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) MOGAD is a rare autoimmune disease of t ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Featured In Biomedwire Editorial Highlighting Biotech's Shift Toward Science-Driven Asset Valuation. Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage ...
According to new CDC data, there were 3.6 million U.S. births in 2025, a 1% decline from 2024 and down 23% since 2007. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results